|
|
 |
|
Viewing report
|
|
|
|
AmerisourceBergen Corp. Jan 12
Standard & Poors, Jan 2012
Abstract
One of the three largest drug distributors; Diversified customer and supplier mixes; Strong liquidity; and High barriers to entry. Potential for lost contracts; and Narrow business focus The ratings on Chesterbrook, Pa.-based drug distributor AmerisourceBergen Corp. (ABC) reflect Standard & Poor's Ratings Services' fiscal 2012 expectations for low single-digit revenue growth, in line with our expectation for the industry. We believe revenues will remain pressured by the conversion of branded drugs to generic. We believe ABC will continue growing, based on the company's consistent performance and generally favorable industry dynamics, which should partly offset the effects of the weak U.S. economy. Acquisitions could further support the company's growth, but we do not expect any that would alter its 'modest' financial...
Companies mentioned in this report are: AmerisourceBergen Corp.
Action: Review
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research Type: Full Analysis
|
|
|
|
